Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cadrenal Therapeutics (CVKD) Q1 2025 Earnings
CVKD
13
Mar
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-2.25
-1.53
-0.8
-0.08
Details
Expected EPS
-1.72
Actual EPS
-2.03
Surprise EPS
-0.31
Surprise Percent
+18.02%
Description
Cadrenal Therapeutics (CVKD) has reported earnings of -2.03 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login